VJOncology is committed to improving our service to you

VJVirtual | ANNOUNCE: doxorubicin + olaratumab in advanced soft tissue sarcomas

VJOncology is committed to improving our service to you

Robin Jones

Robin Jones, MBBS, MRCP, MD (Res), Royal Marsden NHS Foundation Trust, London, UK, updates us on recent results published from the ANNOUNCE Phase III study which evaluated the addition of olaratumab to doxorubicin in patients with advanced/metastatic soft tissue sarcoma. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).

Share this video  
Similar topics

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter